CIBC Private Wealth Group’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
PCM
AAM
TAL
CIBC Private Wealth Group's AMED Position: Q2 2025 in Review
CIBC Private Wealth Group sold out of Amedisys (AMED) in Q2 2025, closing a stake of 254 shares — an estimated $23.2K sold.
CIBC Private Wealth Group first reported a position in AMED in Q1 2024 and held it in 5 quarters. The position peaked at $23.2K in Q1 2025. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.
- CIBC Private Wealth Group reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
- CIBC Private Wealth Group sold 254 Amedisys shares in Q2 2025, an estimated $23.2K.
- CIBC Private Wealth Group first reported a position in Amedisys in Q1 2024 and held it in 5 quarters.
- CIBC Private Wealth Group's Amedisys position peaked at $23.2K in Q1 2025.
- 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.
Based on CIBC Private Wealth Group's 13F filing for Q2 2025, filed 12 Aug 2025.